[account_shop_links]
Phase I Study Trends and Market Outlook (2013)
$4,900.00 – $9,800.00
Licensing Options
- SINGLE-USER LICENSE
A Single-User License allows access to an individual user.
- ENTERPRISE-WIDE LICENSE
An Enterprise-Wide License allows access to all employees and sites within an organization.
Report Overview
ISR’s report surveyed 119 respondents with responsibility and decision-making for Phase I study conduct and outsourcing activities. This report provides novel, first-hand insight into phase-specific study trends and the use of service providers for Phase I studies.
What you will learn:
- How study complexity, the use of patient populations, using multiple sites, and geographic locations will impact sponsor activities and CRO needs
- Current and expected volume of Phase I trials for various sponsor segments
- Outsourcing market dynamics, including expectations for study distribution among types of service providers, dollar value of outsourced studies, and sponsors’ in-house Phase I capabilities
- Sponsor preferences for 22 different Phase I service providers and the attributes seen as most important when selecting a Phase I provider
How you can use this report:
For Sponsors:
- Determine to what degree access to patient populations, alternative geographies, and multi-site and multi-country studies should figure into your strategic planning
- Benchmark internal policies to select service providers and identify which of 22 service providers may be the best fit your organizational needs
For Service Providers:
- Plan for sponsors’ anticipated increase/decrease in study volume, identify needs for anticipated future study complexity, and for their upcoming Phase I studies
- Understand the competitive environment and how to best position your service offerings
Report Contents:
- An Analysis of Phase I Market Dynamics, including current and future study volume and outsourcing
- Selection of Phase I Service Providers
- Geographical Analysis
- Appendix of Charts and Graph